Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure
暂无分享,去创建一个
T. Arias | J. Díez | J. Barba | G. Zalba | B. Lopez | O. Beloqui | E. de Teresa | J. Beaumont | J. Gómez-Doblas | F. Valencia | B. López
[1] Michael Müller,et al. Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.
[2] S. Wiedmann,et al. Association between PPARalpha gene polymorphisms and myocardial infarction. , 2008, Clinical science.
[3] T. Arias,et al. Overexpression of human truncated peroxisome proliferator-activated receptor alpha induces apoptosis in HL-1 cardiomyocytes. , 2008, Cardiovascular research.
[4] D. Kelly,et al. The PPAR trio: regulators of myocardial energy metabolism in health and disease. , 2008, Journal of molecular and cellular cardiology.
[5] B. Janssen,et al. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload. , 2008, Cardiovascular research.
[6] C. Des Rosiers,et al. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts. , 2008, American journal of physiology. Heart and circulatory physiology.
[7] Bruce D. Johnson,et al. Genetics and pharmacogenetics in heart failure , 2007, Current heart failure reports.
[8] D. Lacroix,et al. The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy , 2007, Journal of cardiovascular pharmacology.
[9] T. Pineau,et al. Role of oxidative stress in cardiac dysfunction of PPARα−/− mice , 2007 .
[10] Arantxa González,et al. Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. , 2006, Cardiovascular research.
[11] A. Morris,et al. Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: A Go-DARTS study , 2005, Nuclear receptor.
[12] S. Kersten,et al. Peroxisome proliferator-activated receptor α target genes , 2004, Cellular and Molecular Life Sciences CMLS.
[13] G. J. van der Vusse,et al. Peroxisome Proliferator-Activated Receptor (PPAR) &agr; and PPAR&bgr;/&dgr;, but not PPAR&ggr;, Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism , 2003, Circulation research.
[14] P. Herrero,et al. Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease , 2003, Hypertension.
[15] Stefan Neubauer,et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. , 2002, Journal of the American College of Cardiology.
[16] H. Hense,et al. Peroxisome Proliferator–Activated Receptor &agr; Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension , 2002, Circulation.
[17] T. Kurtz,et al. Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial Hypertrophy* , 2001, The Journal of Biological Chemistry.
[18] T. Ono,et al. Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity* , 2000, The Journal of Biological Chemistry.
[19] W. Kannel,et al. Incidence and Epidemiology of Heart Failure , 2000, Heart Failure Reviews.
[20] J. Peters,et al. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants. , 2000, Pharmacogenetics.
[21] P. Talmud,et al. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects , 2000, Diabetologia.
[22] J. Emparanza,et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. , 2000, Circulation.
[23] K. Griffin,et al. A Carboxyl-terminal Extension of the Zinc Finger Domain Contributes to the Specificity and Polarity of Peroxisome Proliferator-activated Receptor DNA Binding* , 1998, The Journal of Biological Chemistry.
[24] N J Izzo,et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] O. Mcbride,et al. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.
[26] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Pineau,et al. Role of oxidative stress in cardiac dysfunction of PPARalpha-/- mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[28] J. Huss,et al. Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.
[29] R. Smolenski,et al. Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart. , 2003, Cellular & molecular biology letters.
[30] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. 1977. , 1992, Biotechnology.